289 related articles for article (PubMed ID: 28280714)
1. Anti-Biofilm Activity of a Long-Chain Fatty Aldehyde from Antarctic
Casillo A; Papa R; Ricciardelli A; Sannino F; Ziaco M; Tilotta M; Selan L; Marino G; Corsaro MM; Tutino ML; Artini M; Parrilli E
Front Cell Infect Microbiol; 2017; 7():46. PubMed ID: 28280714
[No Abstract] [Full Text] [Related]
2. Anti-biofilm activity of pseudoalteromonas haloplanktis tac125 against staphylococcus epidermidis biofilm: Evidence of a signal molecule involvement?
Parrilli E; Papa R; Carillo S; Tilotta M; Casillo A; Sannino F; Cellini A; Artini M; Selan L; Corsaro MM; Tutino ML
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):104-13. PubMed ID: 25816412
[TBL] [Abstract][Full Text] [Related]
3. Pentadecanal inspired molecules as new anti-biofilm agents against Staphylococcus epidermidis.
Ricciardelli A; Casillo A; Papa R; Monti DM; Imbimbo P; Vrenna G; Artini M; Selan L; Corsaro MM; Tutino ML; Parrilli E
Biofouling; 2018 Nov; 34(10):1110-1120. PubMed ID: 30698031
[TBL] [Abstract][Full Text] [Related]
4. Anti-biofilm activity of the Antarctic marine bacterium Pseudoalteromonas haloplanktis TAC125.
Papa R; Parrilli E; Sannino F; Barbato G; Tutino ML; Artini M; Selan L
Res Microbiol; 2013 Jun; 164(5):450-6. PubMed ID: 23411371
[TBL] [Abstract][Full Text] [Related]
5. Large-scale biofilm cultivation of Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 for physiologic studies and drug discovery.
Parrilli E; Ricciardelli A; Casillo A; Sannino F; Papa R; Tilotta M; Artini M; Selan L; Corsaro MM; Tutino ML
Extremophiles; 2016 Mar; 20(2):227-34. PubMed ID: 26847199
[TBL] [Abstract][Full Text] [Related]
6. Pentadecanal and pentadecanoic acid coatings reduce biofilm formation of Staphylococcus epidermidis on PDMS.
Ricciardelli A; Casillo A; Corsaro MM; Tutino ML; Parrilli E; van der Mei HC
Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32105313
[TBL] [Abstract][Full Text] [Related]
7. Total alkaloids of Sophora alopecuroides and matrine inhibit auto-inducer 2 in the biofilms of Staphylococcus epidermidis.
Jia F; Zhou Q; Li X; Zhou X
Microb Pathog; 2019 Nov; 136():103698. PubMed ID: 31470047
[TBL] [Abstract][Full Text] [Related]
8. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
[TBL] [Abstract][Full Text] [Related]
9. Environmental conditions shape the biofilm of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Ricciardelli A; Casillo A; Vergara A; Balasco N; Corsaro MM; Tutino ML; Parrilli E
Microbiol Res; 2019 Jan; 218():66-75. PubMed ID: 30454660
[TBL] [Abstract][Full Text] [Related]
10. Genome-scale metabolic reconstruction and constraint-based modelling of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Fondi M; Maida I; Perrin E; Mellera A; Mocali S; Parrilli E; Tutino ML; Liò P; Fani R
Environ Microbiol; 2015 Mar; 17(3):751-66. PubMed ID: 24889559
[TBL] [Abstract][Full Text] [Related]
11. γ-Alkylidene-γ-lactones and isobutylpyrrol-2(5H)-ones analogues to rubrolides as inhibitors of biofilm formation by gram-positive and gram-negative bacteria.
Pereira UA; Barbosa LC; Maltha CR; Demuner AJ; Masood MA; Pimenta AL
Bioorg Med Chem Lett; 2014 Feb; 24(4):1052-6. PubMed ID: 24484899
[TBL] [Abstract][Full Text] [Related]
12. Autoinducer-2 increases biofilm formation via an ica- and bhp-dependent manner in Staphylococcus epidermidis RP62A.
Xue T; Ni J; Shang F; Chen X; Zhang M
Microbes Infect; 2015 May; 17(5):345-52. PubMed ID: 25637952
[TBL] [Abstract][Full Text] [Related]
13. Mevalonolactone: an inhibitor of Staphylococcus epidermidis adherence and biofilm formation.
Scopel M; Abraham WR; Antunes AL; Henriques AT; Macedo AJ
Med Chem; 2014 May; 10(3):246-51. PubMed ID: 24111986
[TBL] [Abstract][Full Text] [Related]
14. Short chain fatty acids produced by Cutibacterium acnes inhibit biofilm formation by Staphylococcus epidermidis.
Nakamura K; O'Neill AM; Williams MR; Cau L; Nakatsuji T; Horswill AR; Gallo RL
Sci Rep; 2020 Dec; 10(1):21237. PubMed ID: 33277548
[TBL] [Abstract][Full Text] [Related]
15. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections?
Lönn-Stensrud J; Landin MA; Benneche T; Petersen FC; Scheie AA
J Antimicrob Chemother; 2009 Feb; 63(2):309-16. PubMed ID: 19098295
[TBL] [Abstract][Full Text] [Related]
16. Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Colarusso A; Lauro C; Calvanese M; Parrilli E; Tutino ML
Microb Cell Fact; 2022 Oct; 21(1):211. PubMed ID: 36242022
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.
Villain-Guillot P; Gualtieri M; Bastide L; Leonetti JP
Antimicrob Agents Chemother; 2007 Sep; 51(9):3117-21. PubMed ID: 17606690
[TBL] [Abstract][Full Text] [Related]
18. Different sensitivity levels to norspermidine on biofilm formation in clinical and commensal Staphylococcus epidermidis strains.
Ramón-Peréz ML; Díaz-Cedillo F; Contreras-Rodríguez A; Betanzos-Cabrera G; Peralta H; Rodríguez-Martínez S; Cancino-Diaz ME; Jan-Roblero J; Cancino Diaz JC
Microb Pathog; 2015 Feb; 79():8-16. PubMed ID: 25549879
[TBL] [Abstract][Full Text] [Related]
19. Engineered marine Antarctic bacterium Pseudoalteromonas haloplanktis TAC125: a promising micro-organism for the bioremediation of aromatic compounds.
Papa R; Parrilli E; Sannia G
J Appl Microbiol; 2009 Jan; 106(1):49-56. PubMed ID: 19120609
[TBL] [Abstract][Full Text] [Related]
20. Exocellular peptides from Antarctic psychrophile Pseudoalteromonas Haloplanktis.
Mitova M; Tutino ML; Infusini G; Marino G; De Rosa S
Mar Biotechnol (NY); 2005; 7(5):523-31. PubMed ID: 15988629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
